These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35751547)

  • 1. The use of azathioprine in atopic dermatitis: A review.
    Bracho-Borro M; Franco-Ruiz PA; Magaña M
    Dermatol Ther; 2022 Sep; 35(9):e15665. PubMed ID: 35751547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azathioprine: its uses in dermatology.
    Chavez-Alvarez S; Herz-Ruelas M; Villarreal-Martinez A; Ocampo-Candiani J; Garza-Garza R; Gomez-Flores M
    An Bras Dermatol; 2020; 95(6):731-736. PubMed ID: 33250113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring.
    Fuggle NR; Bragoli W; Mahto A; Glover M; Martinez AE; Kinsler VA
    J Am Acad Dermatol; 2015 Jan; 72(1):108-14. PubMed ID: 25440430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safety of azathioprine therapy adjusted to thiopurine methyltransferase activity in the treatment of infantile atopic dermatitis. Report on 7 cases].
    Martel RM; Melwani P; Islas D; Peñate Y; Borrego L
    Actas Dermosifiliogr; 2010 Jun; 101(5):415-20. PubMed ID: 20525484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Retrospective Study of Systemic Treatment of Severe Atopic Dermatitis With Azathioprine: Effectiveness and Tolerance in 11 Pediatric Patients.
    Noguera-Morel L; Knöpfel N; Torrelo A; Hernández-Martín A
    Actas Dermosifiliogr (Engl Ed); 2019 Apr; 110(3):227-231. PubMed ID: 30376955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further experience of using azathioprine in the treatment of severe atopic dermatitis.
    Hughes R; Collins P; Rogers S
    Clin Exp Dermatol; 2008 Nov; 33(6):710-1. PubMed ID: 18681884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on systemic therapies for atopic dermatitis.
    Denby KS; Beck LA
    Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):421-6. PubMed ID: 22622476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
    Meggitt SJ; Gray JC; Reynolds NJ
    Lancet; 2006 Mar; 367(9513):839-46. PubMed ID: 16530578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
    Schram ME; Roekevisch E; Leeflang MM; Bos JD; Schmitt J; Spuls PI
    J Allergy Clin Immunol; 2011 Aug; 128(2):353-9. PubMed ID: 21514637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-topical management of recalcitrant paediatric atopic dermatitis.
    Chong JH; Koh MJA
    Arch Dis Child; 2017 Jul; 102(7):681-686. PubMed ID: 28209661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression.
    Murphy LA; Atherton D
    Br J Dermatol; 2002 Aug; 147(2):308-15. PubMed ID: 12174104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine in dermatological practice. An overview with special emphasis on its use in non-bullous inflammatory dermatoses.
    Scerri L
    Adv Exp Med Biol; 1999; 455():343-8. PubMed ID: 10599368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atopic dermatitis: phototherapy and systemic therapy.
    Davis DM; Borok J; Udkoff J; Lio P; Spergel J
    Semin Cutan Med Surg; 2017 Sep; 36(3):118-123. PubMed ID: 28895958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral azathioprine for recalcitrant pediatric atopic dermatitis: clinical response and thiopurine monitoring.
    Caufield M; Tom WL
    J Am Acad Dermatol; 2013 Jan; 68(1):29-35. PubMed ID: 22892285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
    Roekevisch E; Spuls PI; Kuester D; Limpens J; Schmitt J
    J Allergy Clin Immunol; 2014 Feb; 133(2):429-38. PubMed ID: 24269258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical improvement and significant reduction of total serum IgE in patients suffering from severe atopic dermatitis treated with oral azathioprine.
    Kuanprasert N; Herbert O; Barnetson RS
    Australas J Dermatol; 2002 May; 43(2):125-7. PubMed ID: 11982569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults.
    Hon KL; Ching GK; Leung TF; Chow CM; Lee KK; Ng PC
    J Dermatolog Treat; 2009; 20(3):141-5. PubMed ID: 18951236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we safely use systemic treatment in atopic dermatitis during the COVID-19 pandemic? Overview of selected conventional and biologic systemic therapies.
    Marko M; Pawliczak R
    Expert Rev Clin Immunol; 2021 Jun; 17(6):619-627. PubMed ID: 33866905
    [No Abstract]   [Full Text] [Related]  

  • 19. Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial.
    Gerbens LAA; Hamann SAS; Brouwer MWD; Roekevisch E; Leeflang MMG; Spuls PI
    Br J Dermatol; 2018 Jun; 178(6):1288-1296. PubMed ID: 29237228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azathioprine in dermatology: a survey of current practice in the U.K.
    Tan BB; Lear JT; Gawkrodger DJ; English JS
    Br J Dermatol; 1997 Mar; 136(3):351-5. PubMed ID: 9115914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.